Breast Cancer, Colorectal Cancer, Lung Cancer
Conditions
Keywords
IBM Watson, Clinical Decision Support System, Patient Preferences, 15-226
Brief summary
The purpose of this study is to learn what cancer patients think about IBM Watson Oncology. IBM Watson Oncology is a computer program designed to help inform oncologists about the best chemotherapy choices for their patients. The investigators will conduct focus groups with cancer patients who have received chemotherapy treatment at MSK in order to understand cancer patients' thoughts about IBM Watson Oncology.
Interventions
BEHAVIORALFocus groups
After the presentation of the of IBM Watson Oncology at the opening of the focus group, participants will be asked to fill out a de-identified brief 15-item questionnaire to assess participants' first impressions of IBM Watson Oncology. The questionnaire will be self administered, and will take approximately 5 minutes to complete. Completed questionnaires will be collected by a member of the study staff, and the focus group will proceed with introductions. The focus group will be audio recorded from the completion of the introductions and notes will be taken. The focus group guide will address the study aims. At the end of the focus group, participants will complete a 7-item questionnaire to capture simple demographic information including education, income, and health literacy. This questionnaire will take 3-5 minutes to complete.
Sponsors
Memorial Sloan Kettering Cancer Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* MSKCC patient 18 years or older * Breast, lung, or colorectal cancer MSK patient as per EMR or clinician judgment having either: * Chemotherapeutic adjuvant or neoadjuvant treatment with the first chemo visit occurring within the past 8 months and primary treatment (i.e., surgery), occurring within the past 6 months)at MSK * OR chemotherapeutic treatment for metastatic disease with the first chemo visit occurring within the past 8 months at MSK * OR chemotherapeutic treatment through an on-going MSK clinical trial as per clinician * Residing in New York metro-area
Exclusion criteria
* Non-English speakers because we do not have the resources to conduct and translate the focus groups into other languages * Patients who are not or will not receive their cancer care at MSKCC. * Patient unwilling or unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Acceptability of IBM Watson Oncology | 1 year | Data collected through the brief questionnaires (e.g.,initial impressions of IBM Watson Oncology, sociodemographics) will be entered into an SPSS data file on the secure MSK server. |
Countries
United States
Outcome results
None listed